RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Vitamin A deficiency due to bi-allelic mutation of RBP4: There's more to it than meets the eye.
|
27892788 |
2017 |
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Exome analysis identified a novel mutation in the RBP4 gene in a consanguineous pedigree with retinal dystrophy and developmental abnormalities.
|
23189188 |
2012 |
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Exome analysis identified a novel mutation in the RBP4 gene in a consanguineous pedigree with retinal dystrophy and developmental abnormalities.
|
23189188 |
2012 |
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Biochemical but not clinical vitamin A deficiency results from mutations in the gene for retinol binding protein.
|
10232633 |
1999 |
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis.
|
9888420 |
1999 |
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Phenotype in retinol deficiency due to a hereditary defect in retinol binding protein synthesis.
|
9888420 |
1999 |
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
RETINAL DYSTROPHY, IRIS COLOBOMA, AND COMEDOGENIC ACNE SYNDROME
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
Biochemical Basis for Dominant Inheritance, Variable Penetrance, and Maternal Effects in RBP4 Congenital Eye Disease.
|
25910211 |
2015 |
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10
|
0.600 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 10
|
0.600 |
Biomarker
|
disease |
CTD_human |
|
|
|
Polycystic Ovary Syndrome
|
0.340 |
Biomarker
|
disease |
BEFREE |
Although serum RBP4 levels were increased in younger women with PCOS compared with age-matched non-PCOS controls, RBP4 does not seem to be a good marker of insulin resistance or other metabolic derangements in women with PCOS.
|
31051472 |
2019 |
Polycystic Ovary Syndrome
|
0.340 |
Biomarker
|
disease |
BEFREE |
We aimed to elucidate the frequency of the SNPs in the ADIPOQ, RBP4 and BCMO1genes in a population of Caucasian Polish women with polycystic ovary syndrome (PCOS), and to evaluate the possible associations between these variants and the susceptibility to PCOS.
|
29428584 |
2018 |
Polycystic Ovary Syndrome
|
0.340 |
AlteredExpression
|
disease |
LHGDN |
In addition to elevated serum RBP4 levels in PCOS women (P < 0.05), RBP4 protein levels were significantly greater in sc and om adipose tissue of PCOS women (P < 0.05 and P < 0.05, respectively).
|
17456573 |
2007 |
Polycystic Ovary Syndrome
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
In addition to elevated serum RBP4 levels in PCOS women (P < 0.05), RBP4 protein levels were significantly greater in sc and om adipose tissue of PCOS women (P < 0.05 and P < 0.05, respectively).
|
17456573 |
2007 |
Polycystic Ovary Syndrome
|
0.340 |
Biomarker
|
disease |
CTD_human |
In addition to elevated serum RBP4 levels in PCOS women (P < 0.05), RBP4 protein levels were significantly greater in sc and om adipose tissue of PCOS women (P < 0.05 and P < 0.05, respectively).
|
17456573 |
2007 |
Polycystic Ovary Syndrome
|
0.340 |
AlteredExpression
|
disease |
LHGDN |
The levels of serum RBP4 were elevated in PCOS women compared with the control (11.69 +/- 6.72 versus 7.75 +/- 5.96 microg/mL, p = 0.006).
|
17526940 |
2006 |
Heart failure
|
0.320 |
Biomarker
|
disease |
BEFREE |
Limited data suggest that RBP4 promotes inflammatory damage to cardiomyocytes and participates in the development of heart failure (HF).
|
29972826 |
2018 |
Congestive heart failure
|
0.320 |
Biomarker
|
disease |
BEFREE |
Limited data suggest that RBP4 promotes inflammatory damage to cardiomyocytes and participates in the development of heart failure (HF).
|
29972826 |
2018 |
Heart failure
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
A prediction model using circulating RBP4 concentration and readily available clinical parameters accurately discriminated ATTR V122I amyloidosis from nonamyloid HF in a case-matched cohort.
|
28196196 |
2017 |
Congestive heart failure
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
A prediction model using circulating RBP4 concentration and readily available clinical parameters accurately discriminated ATTR V122I amyloidosis from nonamyloid HF in a case-matched cohort.
|
28196196 |
2017 |
Vitamin A Deficiency
|
0.320 |
GeneticVariation
|
disease |
BEFREE |
Bi-allelic mutations in RBP4 were identified (c.248+1G>A), consistent with a diagnosis of inherited vitamin A deficiency.
|
27892788 |
2017 |
Heart failure
|
0.320 |
Biomarker
|
disease |
CTD_human |
Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice.
|
26670611 |
2016 |
Congestive heart failure
|
0.320 |
Biomarker
|
disease |
CTD_human |
Inhibition of G-protein-coupled Receptor Kinase 2 Prevents the Dysfunctional Cardiac Substrate Metabolism in Fatty Acid Synthase Transgenic Mice.
|
26670611 |
2016 |
Vitamin A Deficiency
|
0.320 |
Biomarker
|
disease |
BEFREE |
Ret heterozygosity increases the incidence and severity of distal bowel aganglionosis induced by vitamin A deficiency in Rbp4(-/-) animals.
|
20110328 |
2010 |